Stryker/SYK

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Stryker

Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. Stryker is also engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. It also offers Fortress, a modular wall system for hospitals and ambulatory surgery centers.

Ticker

SYK

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Kevin Lobo

Employees

52,000

Headquarters

Portage, United States

Stryker Metrics

BasicAdvanced
$130B
Market cap
38.98
P/E ratio
$8.75
EPS
0.93
Beta
$3.10
Dividend rate
0.94%
Dividend yield
$130B
0.92507
$361.41
$249.98
1.3M
$3.10
1.71
0.987
56.369
67.103
35.08%
53.566
8.82%
18.64%
10.60%
38.984
6.198
6.777
76.479
1.06%
0.91%
0.94%
10.61%
27.33%
12.62%
25.19%
1.35%

What the Analysts think about Stryker

Analyst Ratings

Majority rating from 31 analysts.
Buy

Stryker Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
15.02% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$5.2B
-9.84%
Net income
$788M
-31.06%
Profit margin
15.02%
-23.56%

Stryker Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 6.17%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.54
$2.46
$3.46
$2.50
-
Expected
$2.38
$2.43
$3.27
$2.35
$2.79
Surprise
6.86%
1.03%
5.86%
6.17%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

Jun
28
Stryker
Dividend·Ex-dividend
Jul
31
Stryker
Dividend·Payment
$0.80
Per share

FAQs

What’s the current market cap for Stryker stock?

Stryker (SYK) has a market cap of $130B as of June 17, 2024.

What is the P/E ratio for Stryker stock?

The price to earnings (P/E) ratio for Stryker (SYK) stock is 38.98 as of June 17, 2024.

Does Stryker stock pay dividends?

Yes, the Stryker (SYK) stock pays dividends to shareholders. As of June 17, 2024, the dividend rate is $3.1 and the yield is 0.94%. Stryker has a payout ratio of 35.08% on a trailing twelve-month basis.

When is the next Stryker dividend payment date?

The next Stryker (SYK) dividend payment is scheduled for July 31, 2024.

What is the beta indicator for Stryker?

Stryker (SYK) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Stryker stock price target?

The target price for Stryker (SYK) stock is $379.61, which is NaN% below the current price of $. This is an average based on projections from 26 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Stryker stock

Buy or sell Stryker stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing